Skip to main navigation Skip to search Skip to main content

Reigning Blood Does Thrombopoietin Signalling Hold the Key to New Treatments for Myeloid Malignancies?

Activity: Talk or presentation › Invited talk

Description

Yorkshire Immunology Group Meeting
Period17 May 2017
Held atUNIVERSITY OF LEEDS
Degree of RecognitionRegional